Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in NSCLC
by on Friday, August 17th, 2012 | No Comments
Condition: Non Small Cell Lung Cancer
Interventions: Drug: AMG 386 Dose 1; Drug: AMG 386 Dose 2
Sponsors: Amgen; Amgen
Recruiting – verified August 2012
Read the original post: Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in NSCLC
